首页 > 最新文献

Cardiovascular Journal of Africa最新文献

英文 中文
Correlation between mitral valve area and left atrial function in rheumatic mitral valve stenosis patients. 风湿性二尖瓣狭窄患者二尖瓣面积与左心房功能之间的相关性。
IF 0.7 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-23 Epub Date: 2022-12-13 DOI: 10.5830/CVJA-2022-059
Ahmed Fareed, Mohamed Hamed, Fathy Makaldy, Omar Saleh

Background: Rheumatic heart disease (RHD) continues to be one of the leading causes of cardiovascular morbidity and mortality. The mitral valve frequently develops mitral stenosis (MS), and it is the most prevalent valve lesion in patients with chronic RHD. Left atrial (LA) functional impairment is associated with rheumatic MS.

Aim: The aim of this study was to evaluate the association between LA function and mitral valve area (MVA) in rheumatic MS patients, and to assess the echocardiographic parameters in sinus rhythm and atrial fibrillation (AF) patients.

Methods: This was a cross-sectional, descriptive study that involved patients with rheumatic MS. Patients underwent a standard 12-lead electrocardiogram and echocardiographic examination. MVA was assessed and correlated with LA function. Comparison was made between sinus rhythm and AF patients.

Results: Eighty-one patients with rheumatic MS were included in this study, with 71.6% of them having associated MR. MVA showed a statistically highly significant positive correlation with LA and right ventricular (RV) function, and a statistically significant/highly significant negative correlation with their dimensions. A higher percentage of patients with severe MS was in AF (58.1%).

Conclusions: There was a positive correlation between LA function and MVA in rheumatic MS patients. AF was related to the severity of MS.

背景:风湿性心脏病(RHD)仍然是心血管疾病发病率和死亡率的主要原因之一。二尖瓣经常发生二尖瓣狭窄(MS),是慢性风湿性心脏病患者最常见的瓣膜病变。目的:本研究旨在评估风湿性二尖瓣狭窄患者左心房(LA)功能和二尖瓣面积(MVA)之间的关系,并评估窦性心律和房颤(AF)患者的超声心动图参数:这是一项横断面描述性研究,涉及风湿性多发性硬化症患者。患者接受了标准的 12 导联心电图和超声心动图检查。评估了MVA并将其与LA功能相关联。对窦性心律和房颤患者进行了比较:本研究共纳入 81 例风湿性多发性硬化症患者,其中 71.6% 的患者伴有 MR。MVA与LA和右心室(RV)功能呈统计学上高度显著的正相关,而与它们的尺寸呈统计学上显著/高度显著的负相关。严重多发性硬化患者中房颤患者的比例较高(58.1%):结论:风湿性多发性硬化症患者的 LA 功能与 MVA 呈正相关。房颤与多发性硬化症的严重程度有关。
{"title":"Correlation between mitral valve area and left atrial function in rheumatic mitral valve stenosis patients.","authors":"Ahmed Fareed, Mohamed Hamed, Fathy Makaldy, Omar Saleh","doi":"10.5830/CVJA-2022-059","DOIUrl":"10.5830/CVJA-2022-059","url":null,"abstract":"<p><strong>Background: </strong>Rheumatic heart disease (RHD) continues to be one of the leading causes of cardiovascular morbidity and mortality. The mitral valve frequently develops mitral stenosis (MS), and it is the most prevalent valve lesion in patients with chronic RHD. Left atrial (LA) functional impairment is associated with rheumatic MS.</p><p><strong>Aim: </strong>The aim of this study was to evaluate the association between LA function and mitral valve area (MVA) in rheumatic MS patients, and to assess the echocardiographic parameters in sinus rhythm and atrial fibrillation (AF) patients.</p><p><strong>Methods: </strong>This was a cross-sectional, descriptive study that involved patients with rheumatic MS. Patients underwent a standard 12-lead electrocardiogram and echocardiographic examination. MVA was assessed and correlated with LA function. Comparison was made between sinus rhythm and AF patients.</p><p><strong>Results: </strong>Eighty-one patients with rheumatic MS were included in this study, with 71.6% of them having associated MR. MVA showed a statistically highly significant positive correlation with LA and right ventricular (RV) function, and a statistically significant/highly significant negative correlation with their dimensions. A higher percentage of patients with severe MS was in AF (58.1%).</p><p><strong>Conclusions: </strong>There was a positive correlation between LA function and MVA in rheumatic MS patients. AF was related to the severity of MS.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10473168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Very rare malposition of central venous catheter in cardiac surgery patients. 心脏手术患者中非常罕见的中心静脉导管错位。
IF 0.7 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-23 Epub Date: 2023-02-06 DOI: 10.5830/CVJA-2022-062
Nursen Tanrikulu, Ali Haspolat, Ali Sefik Koprulu

Malposition of a catheter is found in approximately 7% of cases after central venous catheterisation. This may result in haemorrhage, venous thrombosis and functional impairment, depending on the injury to the vessel wall. Uncomplicated catheterisation, easy aspiration of blood and monitoring of catheterisation do not guarantee correct placement of the catheter. In our rare case series, we share our experience of four cases of malposition into the left internal mammary vein (LIMV) that we experienced in a three-year period. The thinness and fragility of the vessel wall, particularly, increases the probability of complications in malposition into the LIMV. Administration of a catheter through the right jugular vein is associated with the lowest incidence of malposition. Performing the procedure under the guidance of ultrasonography (USG) and confirmation of the catheter position after puncture using one of the USG techniques will minimise the probability of malposition. In addition, a lung X-ray should immediately be taken, and venography and fluoroscopy should be considered in the presence of suspicion.

约有 7% 的病例在接受中心静脉导管插入术后会发现导管错位。这可能导致大出血、静脉血栓和功能障碍,具体取决于血管壁的损伤情况。不复杂的导管置入、血液的轻松抽吸和导管置入的监测并不能保证导管的正确置入。在我们罕见的病例系列中,我们分享了三年内四例左乳内静脉(LIMV)置管错误的经验。左乳内静脉血管壁薄且脆弱,这尤其增加了导管错置并发症的发生几率。通过右颈静脉置入导管的错位发生率最低。在超声波检查(USG)的指导下进行手术,并在穿刺后使用其中一种 USG 技术确认导管位置,将最大限度地降低导管错位的概率。此外,应立即进行肺部 X 光检查,如果有怀疑,应考虑进行静脉造影和透视检查。
{"title":"Very rare malposition of central venous catheter in cardiac surgery patients.","authors":"Nursen Tanrikulu, Ali Haspolat, Ali Sefik Koprulu","doi":"10.5830/CVJA-2022-062","DOIUrl":"10.5830/CVJA-2022-062","url":null,"abstract":"<p><p>Malposition of a catheter is found in approximately 7% of cases after central venous catheterisation. This may result in haemorrhage, venous thrombosis and functional impairment, depending on the injury to the vessel wall. Uncomplicated catheterisation, easy aspiration of blood and monitoring of catheterisation do not guarantee correct placement of the catheter. In our rare case series, we share our experience of four cases of malposition into the left internal mammary vein (LIMV) that we experienced in a three-year period. The thinness and fragility of the vessel wall, particularly, increases the probability of complications in malposition into the LIMV. Administration of a catheter through the right jugular vein is associated with the lowest incidence of malposition. Performing the procedure under the guidance of ultrasonography (USG) and confirmation of the catheter position after puncture using one of the USG techniques will minimise the probability of malposition. In addition, a lung X-ray should immediately be taken, and venography and fluoroscopy should be considered in the presence of suspicion.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10650631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of pregnancy with pulmonary hypertension: low risk or a false dawn? 妊娠合并肺动脉高压的结果:低风险还是假曙光?
IF 0.7 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-23 Epub Date: 2023-04-06 DOI: 10.5830/CVJA-2023-014
Onyedika J Ilonze
{"title":"Outcomes of pregnancy with pulmonary hypertension: low risk or a false dawn?","authors":"Onyedika J Ilonze","doi":"10.5830/CVJA-2023-014","DOIUrl":"10.5830/CVJA-2023-014","url":null,"abstract":"","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9307249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of spontaneous isolated superior mesenteric arterial dissection with coeliac axis stenosis. 一例自发性孤立肠系膜上动脉夹层伴有腹腔轴狭窄。
IF 0.7 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-23 Epub Date: 2023-03-10 DOI: 10.5830/CVJA-2022-066
Kun Ye, Yong Wang, Shengyun Wan

Spontaneous isolated superior mesenteric arterial dissection with coeliac axis stenosis is rare but serious. We report a case of a 54-year-old male with coeliac axis stenosis who presented with acute superior mesenteric arterial dissection, which caused thrombosis of the branches. This is the first report of the full course of treatment using endovascular repair and laparoscopic surgery to deal with spontaneous isolated superior mesenteric arterial dissection combined with coeliac axis stenosis. This approach has been shown to be safe and effective for yielding short-term results.

自发性孤立肠系膜上动脉夹层伴有腹腔轴狭窄的情况非常罕见,但却很严重。我们报告了一例 54 岁患有腹腔轴狭窄的男性患者,他出现急性肠系膜上动脉夹层并导致分支血栓形成。这是首次报道使用血管内修复术和腹腔镜手术治疗自发性孤立肠系膜上动脉夹层合并腹腔轴狭窄的全过程。事实证明,这种方法既安全又有效,可在短期内见效。
{"title":"A case of spontaneous isolated superior mesenteric arterial dissection with coeliac axis stenosis.","authors":"Kun Ye, Yong Wang, Shengyun Wan","doi":"10.5830/CVJA-2022-066","DOIUrl":"10.5830/CVJA-2022-066","url":null,"abstract":"<p><p>Spontaneous isolated superior mesenteric arterial dissection with coeliac axis stenosis is rare but serious. We report a case of a 54-year-old male with coeliac axis stenosis who presented with acute superior mesenteric arterial dissection, which caused thrombosis of the branches. This is the first report of the full course of treatment using endovascular repair and laparoscopic surgery to deal with spontaneous isolated superior mesenteric arterial dissection combined with coeliac axis stenosis. This approach has been shown to be safe and effective for yielding short-term results.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9211001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertension treatment in sub-Saharan Africa: a systematic review. 撒哈拉以南非洲的高血压治疗:系统综述。
IF 0.7 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-23 Epub Date: 2023-05-25 DOI: 10.5830/CVJA-2022-065
Pauline Cavagna, Céline Leplay, Roland N'Guetta, Kouadio Euloge Kramoh, Ibrahima Bara Diop, Dadhi M Balde, Jean Bruno Mipinda, Michel Azizi, Xavier Jouven, Marie Antignac

Sub-Saharan Africa (SSA) faces the highest rate of hypertension worldwide. Blood pressure (BP) control rests on the association of lifestyle modification and antihypertensive medicines. We aimed to systematically review antihypertensive strategies implemented in SSA to achieve BP control. A systematic search beginning in 2003 was performed in MEDLINE, COCHRANE and EMBASE. We included only original and observational studies in SSA countries. Thirty studies were included from 11 countries. No study was multinational. The number of patients varied from 111 to 897 (median: 294; IQR: 192-478). Overall, 21% of patients received monotherapy, 42.6% two-drug and 26.6% three-drug combinations. Out of all the strategies, renin-angiotensin system (RAS) blockers were mostly prescribed, followed by diuretics and calcium channel blockers. In monotherapy, RAS blockers were the first to be prescribed. Only 10 articles described antihypertensive strategies beyond triple combinations. BP control was highly variable (range: 16.4 to 61.2%). Multicentre studies performed in several SSA countries are needed to ensure international guidelines actually do improve outcomes in SSA.

撒哈拉以南非洲(SSA)是全球高血压发病率最高的地区。血压控制主要依靠改变生活方式和降压药物。我们旨在系统回顾撒哈拉以南非洲地区为实现血压控制而实施的降压策略。从 2003 年开始,我们在 MEDLINE、COCHRANE 和 EMBASE 中进行了系统检索。我们仅纳入了 SSA 国家的原创性和观察性研究。共纳入 11 个国家的 30 项研究。没有一项研究是跨国的。患者人数从 111 到 897 不等(中位数:294;IQR:192-478)。总体而言,21%的患者接受了单一疗法,42.6%的患者接受了两药联合疗法,26.6%的患者接受了三药联合疗法。在所有治疗策略中,肾素-血管紧张素系统(RAS)阻滞剂占大多数,其次是利尿剂和钙通道阻滞剂。在单药治疗中,肾素血管紧张素系统(RAS)阻断剂是最先使用的药物。只有 10 篇文章介绍了三联疗法以外的降压策略。血压控制的差异很大(范围:16.4% 至 61.2%)。需要在几个撒哈拉以南非洲国家开展多中心研究,以确保国际指南确实能改善撒哈拉以南非洲国家的治疗效果。
{"title":"Hypertension treatment in sub-Saharan Africa: a systematic review.","authors":"Pauline Cavagna, Céline Leplay, Roland N'Guetta, Kouadio Euloge Kramoh, Ibrahima Bara Diop, Dadhi M Balde, Jean Bruno Mipinda, Michel Azizi, Xavier Jouven, Marie Antignac","doi":"10.5830/CVJA-2022-065","DOIUrl":"10.5830/CVJA-2022-065","url":null,"abstract":"<p><p>Sub-Saharan Africa (SSA) faces the highest rate of hypertension worldwide. Blood pressure (BP) control rests on the association of lifestyle modification and antihypertensive medicines. We aimed to systematically review antihypertensive strategies implemented in SSA to achieve BP control. A systematic search beginning in 2003 was performed in MEDLINE, COCHRANE and EMBASE. We included only original and observational studies in SSA countries. Thirty studies were included from 11 countries. No study was multinational. The number of patients varied from 111 to 897 (median: 294; IQR: 192-478). Overall, 21% of patients received monotherapy, 42.6% two-drug and 26.6% three-drug combinations. Out of all the strategies, renin-angiotensin system (RAS) blockers were mostly prescribed, followed by diuretics and calcium channel blockers. In monotherapy, RAS blockers were the first to be prescribed. Only 10 articles described antihypertensive strategies beyond triple combinations. BP control was highly variable (range: 16.4 to 61.2%). Multicentre studies performed in several SSA countries are needed to ensure international guidelines actually do improve outcomes in SSA.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9917467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is pre-operative monocyte count-high-density lipoprotein ratio associated with postoperative acute kidney injury in isolated coronary artery bypass grafting? 在孤立的冠状动脉旁路移植术中,术前单核细胞计数-高密度脂蛋白比率与术后急性肾损伤是否相关?
IF 0.7 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-23 Epub Date: 2022-11-24 DOI: 10.5830/CVJA-2022-055
Hüseyin Şaşkın

Objective: Monocyte-to-high-density lipoprotein cholesterol ratio has emerged as an indicator of inflammation and oxidative stress in recent years. The aim of this study was to evaluate the association of monocyte-to-high-density lipoprotein ratio with postoperative acute kidney injury in isolated coronary artery bypass grafting.

Methods: A total of 954 patients (672 males, mean age 60.8 ± 8.2 years), operated on between June 2014 and June 2022, at the same centre by the same team, for isolated coronary artery bypass grafting with cardiopulmonary bypass, whose preoperative serum creatinine level was < 1.5 mg/dl, were enrolled in the study. Patients were placed in group 1 if they had acute kidney injury in the early postoperative period (n = 161) and group 2 comprised those without (n = 793). Univariate and subsequent multivariate logistic regression analysis were done to determine significant clinical factors, and independent predictors of acute kidney injury.

Results: Pre-operative monocyte count (p = 0.0001), monocyte count-high-density lipoprotein cholesterol ratio (p = 0.0001), C-reactive protein (p = 0.0001), erythrocyte sedimentation rate (p = 0.0001), mean platelet volume (p = 0.0001) and postoperative first- and third-day C-reactive protein levels (p = 0.0001) were significantly increased in group 1. Multivariate logistic regression analysis revealed that pre-operative elevated monocyte count (p = 0.0001), monocyte-high-density lipoprotein ratio (p = 0.0001), erythrocyte sedimentation rate (p = 0.0001), postoperative first-day C-reactive protein level (p = 0.0001), postoperative first-third day erythrocyte sedimentation rate (p = 0.002, p = 0.004, respectively) and mean platelet volume (p = 0.02, p = 0.0001, respectively) were independent predictors of early postoperative acute kidney injury in patients who had undergone isolated coronary artery bypass grafting.

Conclusions: Pre-operative monocyte-high-density lipoprotein cholesterol ratio was found to be an independent predictor of acute kidney injury in the early postoperative period of isolated coronary artery bypass grafting.

目的:近年来,单核细胞与高密度脂蛋白胆固醇比值已成为炎症和氧化应激的指标。本研究旨在评估单核细胞-高密度脂蛋白比值与离体冠状动脉搭桥术术后急性肾损伤的关系:研究共纳入954例患者(672例男性,平均年龄(60.8±8.2)岁),这些患者于2014年6月至2022年6月期间在同一中心由同一团队进行分离式冠状动脉搭桥术加心肺旁路手术,术前血清肌酐水平小于1.5 mg/dl。术后早期出现急性肾损伤的患者被分到第一组(161 人),没有出现急性肾损伤的患者被分到第二组(793 人)。研究人员进行了单变量和多变量逻辑回归分析,以确定重要的临床因素和急性肾损伤的独立预测因素:术前单核细胞计数(p = 0.0001)、单核细胞计数-高密度脂蛋白胆固醇比值(p = 0.0001)、C 反应蛋白(p = 0.0001)、红细胞沉降率(p = 0.0001)、平均血小板体积(p = 0.多变量逻辑回归分析显示,术前单核细胞计数升高(p = 0.0001)、单核细胞-高密度脂蛋白比值(p = 0.0001)、红细胞沉降率(p = 0.0001)、术后第 1 天 C 反应蛋白水平(p = 0.0001)、术后第 1-3 天红细胞沉降率(p = 0.002, p = 0.004, respectively)和平均血小板体积(p = 0.02, p = 0.0001, respectively)是孤立冠状动脉旁路移植术患者术后早期急性肾损伤的独立预测因子:结论:研究发现,术前单核细胞-高密度脂蛋白胆固醇比值是孤立冠状动脉旁路移植术术后早期急性肾损伤的独立预测因子。
{"title":"Is pre-operative monocyte count-high-density lipoprotein ratio associated with postoperative acute kidney injury in isolated coronary artery bypass grafting?","authors":"Hüseyin Şaşkın","doi":"10.5830/CVJA-2022-055","DOIUrl":"10.5830/CVJA-2022-055","url":null,"abstract":"<p><strong>Objective: </strong>Monocyte-to-high-density lipoprotein cholesterol ratio has emerged as an indicator of inflammation and oxidative stress in recent years. The aim of this study was to evaluate the association of monocyte-to-high-density lipoprotein ratio with postoperative acute kidney injury in isolated coronary artery bypass grafting.</p><p><strong>Methods: </strong>A total of 954 patients (672 males, mean age 60.8 ± 8.2 years), operated on between June 2014 and June 2022, at the same centre by the same team, for isolated coronary artery bypass grafting with cardiopulmonary bypass, whose preoperative serum creatinine level was < 1.5 mg/dl, were enrolled in the study. Patients were placed in group 1 if they had acute kidney injury in the early postoperative period (<i>n</i> = 161) and group 2 comprised those without (<i>n</i> = 793). Univariate and subsequent multivariate logistic regression analysis were done to determine significant clinical factors, and independent predictors of acute kidney injury.</p><p><strong>Results: </strong>Pre-operative monocyte count (<i>p</i> = 0.0001), monocyte count-high-density lipoprotein cholesterol ratio (<i>p</i> = 0.0001), C-reactive protein (<i>p</i> = 0.0001), erythrocyte sedimentation rate (<i>p</i> = 0.0001), mean platelet volume (<i>p</i> = 0.0001) and postoperative first- and third-day C-reactive protein levels (<i>p</i> = 0.0001) were significantly increased in group 1. Multivariate logistic regression analysis revealed that pre-operative elevated monocyte count (<i>p</i> = 0.0001), monocyte-high-density lipoprotein ratio (<i>p</i> = 0.0001), erythrocyte sedimentation rate (<i>p</i> = 0.0001), postoperative first-day C-reactive protein level (<i>p</i> = 0.0001), postoperative first-third day erythrocyte sedimentation rate (<i>p</i> = 0.002, <i>p</i> = 0.004, respectively) and mean platelet volume (<i>p</i> = 0.02, <i>p</i> = 0.0001, respectively) were independent predictors of early postoperative acute kidney injury in patients who had undergone isolated coronary artery bypass grafting.</p><p><strong>Conclusions: </strong>Pre-operative monocyte-high-density lipoprotein cholesterol ratio was found to be an independent predictor of acute kidney injury in the early postoperative period of isolated coronary artery bypass grafting.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40702907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective study: efficacy of an originator versus a generic formulation of simvastatin in patients who suffer from hyperlipidaemia. 一项回顾性研究:高脂血症患者服用辛伐他汀原研制剂与普通制剂的疗效对比。
IF 0.7 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-23 Epub Date: 2022-12-08 DOI: 10.5830/CVJA-2022-053
J R Snyman, K R Snyman

Background: South Africa is home to a multi-ethnic society with a large range of cultures and lifestyles. Cardiovascular disease is a major cause of morbidity and mortality. South Africa is known to have one of the highest incidence rates of hypercholesterolaemia in the world, especially among the Caucasian population.

Aim: The aim of this retrospective chart review was to establish whether a multisource simvastatin (Simvotin®, Ranbaxy, a Sun Pharma company) maintained the cholesterol-lowering effect after switching from the innovator brand Zocor® (MSD South Africa) in the public-sector hospitals. Since prescribers often doubt the registration requirements of multisource products based on bioequivalence alone, this research was done to confirm similar clinical outcomes in a real-world setting.

Methods: More than 200 charts were identified from patients treated for hyperlipidaemia. Patients were treated for at least six months prior to and again six months after the switching of brands in order to meet criteria to be eligible for inclusion. The lipid values at initiation of therapy as well as before switching (visit 1 and 2) had to be available and again six months after treatment on the multisource product (visit 3).

Results: No significant change was observed in the lipid control after switching, confirming similarity.

Conclusion: This real-world evidence should allay any fears of generic inferiority of this important medicine in the treatment and prevention of high cardiovascular risk in patients requiring lipid-lowering therapy.

背景:南非是一个多民族社会,文化和生活方式多种多样。心血管疾病是发病和死亡的主要原因。目的:本次回顾性病历审查的目的是确定在公立医院使用多来源辛伐他汀(Simvotin®,Ranbaxy,Sun Pharma 公司)替代创新品牌 Zocor®(MSD 南非公司)后是否仍能保持降低胆固醇的效果。由于处方者经常怀疑仅凭生物等效性就能满足多来源产品的注册要求,因此本研究的目的是在实际环境中证实类似的临床结果:方法:从接受高脂血症治疗的患者中找出了 200 多份病历。患者在更换品牌前至少接受了六个月的治疗,在更换品牌后又接受了六个月的治疗,以符合纳入标准。必须提供开始治疗时和转换前(第 1 次和第 2 次)的血脂值,以及使用多来源产品治疗 6 个月后(第 3 次)的血脂值:结果:换药后血脂控制没有明显变化,证实了相似性:这一真实世界的证据应能消除人们对这一重要药物在治疗和预防需要降脂治疗的高心血管风险患者中的非专利劣势的担忧。
{"title":"A retrospective study: efficacy of an originator versus a generic formulation of simvastatin in patients who suffer from hyperlipidaemia.","authors":"J R Snyman, K R Snyman","doi":"10.5830/CVJA-2022-053","DOIUrl":"10.5830/CVJA-2022-053","url":null,"abstract":"<p><strong>Background: </strong>South Africa is home to a multi-ethnic society with a large range of cultures and lifestyles. Cardiovascular disease is a major cause of morbidity and mortality. South Africa is known to have one of the highest incidence rates of hypercholesterolaemia in the world, especially among the Caucasian population.</p><p><strong>Aim: </strong>The aim of this retrospective chart review was to establish whether a multisource simvastatin (Simvotin<sup>®</sup>, Ranbaxy, a Sun Pharma company) maintained the cholesterol-lowering effect after switching from the innovator brand Zocor<sup>®</sup> (MSD South Africa) in the public-sector hospitals. Since prescribers often doubt the registration requirements of multisource products based on bioequivalence alone, this research was done to confirm similar clinical outcomes in a real-world setting.</p><p><strong>Methods: </strong>More than 200 charts were identified from patients treated for hyperlipidaemia. Patients were treated for at least six months prior to and again six months after the switching of brands in order to meet criteria to be eligible for inclusion. The lipid values at initiation of therapy as well as before switching (visit 1 and 2) had to be available and again six months after treatment on the multisource product (visit 3).</p><p><strong>Results: </strong>No significant change was observed in the lipid control after switching, confirming similarity.</p><p><strong>Conclusion: </strong>This real-world evidence should allay any fears of generic inferiority of this important medicine in the treatment and prevention of high cardiovascular risk in patients requiring lipid-lowering therapy.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10374999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive values of stress hyperglycaemia and glycosylated haemoglobin on admission for long-term recovery of cardiac function in patients with acute myocardial infarction after primary percutaneous coronary intervention. 急性心肌梗死患者初次经皮冠状动脉介入治疗后入院时应激性高血糖和糖化血红蛋白对心功能长期恢复的预测价值
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-11-22 DOI: 10.5830/CVJA-2023-056
Jinfeng Xiao, Chuanchao Luo, Lixin Yang

We aimed to explore the predictive values of stress hyperglycaemia (SHG) and glycosylated haemoglobin (HbA1c) levels on admission for long-term recovery of cardiac function in patients with acute myocardial infarction (AMI) after primary percutaneous coronary intervention (PPCI). A total of 210 AMI patients were randomly selected. The levels of SHG and HbA1c were measured on admission, and all patients were treated with PPCI and followed up for one year. According to the recovery status of cardiac function during follow up, the patients were divided into a good recovery group and a poor recovery group. At one year after treatment, there were statistically significant differences in the levels of SHG (6.75 ± 0.69 vs 7.81 ± 0.92 mmol/l) and HbA1c (5.13 ± 0.25 vs 5.91 ± 0.39%) between the good and poor recovery groups (p < 0.05). The levels of SHG and HbA1c were associated with long-term recovery of cardiac function (p < 0.05). The receiver operating characteristic curves were plotted, and the area under the curves of SHG and HbA1c for predicting the long-term recovery of cardiac function were > 0.70. The levels of SHG and HbA1c were closely associated with longterm recovery of cardiac function after PPCI in AMI patients, displaying high predictive values.

我们旨在探讨入院时应激性高血糖(SHG)和糖化血红蛋白(HbA1c)水平对急性心肌梗死(AMI)患者经皮冠状动脉介入治疗(PPCI)后心功能长期恢复的预测价值。随机选取AMI患者210例。入院时测量SHG和HbA1c水平,所有患者均接受PPCI治疗并随访1年。根据随访时心功能恢复情况将患者分为恢复良好组和恢复较差组。治疗1年后,恢复良好组与恢复不良组SHG(6.75±0.69 vs 7.81±0.92 mmol/l)、HbA1c(5.13±0.25 vs 5.91±0.39%)水平比较,差异有统计学意义(p < 0.05)。SHG和HbA1c水平与心功能的长期恢复相关(p < 0.05)。绘制受试者工作特征曲线,SHG和HbA1c曲线下预测心功能长期恢复的面积> 0.70。AMI患者PPCI后SHG和HbA1c水平与心功能的长期恢复密切相关,具有较高的预测价值。
{"title":"Predictive values of stress hyperglycaemia and glycosylated haemoglobin on admission for long-term recovery of cardiac function in patients with acute myocardial infarction after primary percutaneous coronary intervention.","authors":"Jinfeng Xiao, Chuanchao Luo, Lixin Yang","doi":"10.5830/CVJA-2023-056","DOIUrl":"https://doi.org/10.5830/CVJA-2023-056","url":null,"abstract":"<p><p>We aimed to explore the predictive values of stress hyperglycaemia (SHG) and glycosylated haemoglobin (HbA<sub>1c</sub>) levels on admission for long-term recovery of cardiac function in patients with acute myocardial infarction (AMI) after primary percutaneous coronary intervention (PPCI). A total of 210 AMI patients were randomly selected. The levels of SHG and HbA<sub>1c</sub> were measured on admission, and all patients were treated with PPCI and followed up for one year. According to the recovery status of cardiac function during follow up, the patients were divided into a good recovery group and a poor recovery group. At one year after treatment, there were statistically significant differences in the levels of SHG (6.75 ± 0.69 vs 7.81 ± 0.92 mmol/l) and HbA<sub>1c</sub> (5.13 ± 0.25 vs 5.91 ± 0.39%) between the good and poor recovery groups (<i>p</i> < 0.05). The levels of SHG and HbA<sub>1c</sub> were associated with long-term recovery of cardiac function (<i>p</i> < 0.05). The receiver operating characteristic curves were plotted, and the area under the curves of SHG and HbA<sub>1c</sub> for predicting the long-term recovery of cardiac function were > 0.70. The levels of SHG and HbA<sub>1c</sub> were closely associated with longterm recovery of cardiac function after PPCI in AMI patients, displaying high predictive values.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138458039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between epicardial adipose tissue and choroidal vascularity index in patients with hypertension. 高血压患者心外膜脂肪组织与脉络膜血管指数的关系。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-11-20 DOI: 10.5830/CVJA-2023-057
Güvenç Toprak, Muhammet Fatih Bayraktar

Objective: The choroidal vascularity index (CVI) is a method that measures the density of blood vessels in the choroidal layer and can be used to evaluate the effects of hypertension. In this study we aimed to investigate the relationship between epicardial fat thickness (EFT) and CVI in patients with hypertension.

Methods: This prospective study included 112 patients diagnosed with hypertension and 120 healthy individuals. Patients' demographic data such as age, gender, weight, height, body mass index (BMI), smoking status, and presence of coronary artery disease and diabetes mellitus were recorded. BMI was calculated by dividing a patient's weight in kilograms by their height in metres squared. EFT was measured by echocardiography and CVI was calculated using the optical coherence tomography method.

Results: The mean CVI was found to be 66.57 ± 2.21 in the patient group and 69.22 ± 2.39 in the control group and the difference was significant (p < 0.001). The mean EFT was found to be 5.23 ± 3.25 mm in the patients and 2.57 ± 1.97 mm in the control group and the difference was statistically significant (p = 0.003). According to Spearman's correlation analysis, there was a significant positive correlation between BMI and EFT (r = 0.379, p < 0.001) and a significant negative correlation between CVI and EFT (r = -0.412, p < 0.001).

Conclusion: The CVI value was significantly lower and the EFT value was significantly higher in patients with hypertension compared to non-hypertensive patients. There was a significant positive correlation between EFT and BMI and a significant negative correlation between EFT and CVI.

目的:脉络膜血管密度指数(CVI)是一种测量脉络膜层血管密度的方法,可用于评价高血压的影响。在本研究中,我们旨在探讨高血压患者心外膜脂肪厚度(EFT)与CVI的关系。方法:本前瞻性研究纳入112例高血压患者和120例健康人。记录患者的年龄、性别、体重、身高、身体质量指数(BMI)、吸烟状况、有无冠状动脉疾病和糖尿病等人口统计数据。BMI的计算方法是用病人的体重(公斤)除以身高(米)的平方。超声心动图测量EFT,光学相干断层扫描法计算CVI。结果:患者组平均CVI为66.57±2.21,对照组平均CVI为69.22±2.39,差异有统计学意义(p < 0.001)。治疗组EFT均值为5.23±3.25 mm,对照组为2.57±1.97 mm,差异有统计学意义(p = 0.003)。Spearman相关分析显示,BMI与EFT呈显著正相关(r = 0.379, p < 0.001), CVI与EFT呈显著负相关(r = -0.412, p < 0.001)。结论:高血压患者的CVI值明显低于非高血压患者,EFT值明显高于非高血压患者。EFT与BMI呈显著正相关,与CVI呈显著负相关。
{"title":"The relationship between epicardial adipose tissue and choroidal vascularity index in patients with hypertension.","authors":"Güvenç Toprak, Muhammet Fatih Bayraktar","doi":"10.5830/CVJA-2023-057","DOIUrl":"https://doi.org/10.5830/CVJA-2023-057","url":null,"abstract":"<p><strong>Objective: </strong>The choroidal vascularity index (CVI) is a method that measures the density of blood vessels in the choroidal layer and can be used to evaluate the effects of hypertension. In this study we aimed to investigate the relationship between epicardial fat thickness (EFT) and CVI in patients with hypertension.</p><p><strong>Methods: </strong>This prospective study included 112 patients diagnosed with hypertension and 120 healthy individuals. Patients' demographic data such as age, gender, weight, height, body mass index (BMI), smoking status, and presence of coronary artery disease and diabetes mellitus were recorded. BMI was calculated by dividing a patient's weight in kilograms by their height in metres squared. EFT was measured by echocardiography and CVI was calculated using the optical coherence tomography method.</p><p><strong>Results: </strong>The mean CVI was found to be 66.57 ± 2.21 in the patient group and 69.22 ± 2.39 in the control group and the difference was significant (<i>p</i> < 0.001). The mean EFT was found to be 5.23 ± 3.25 mm in the patients and 2.57 ± 1.97 mm in the control group and the difference was statistically significant (<i>p</i> = 0.003). According to Spearman's correlation analysis, there was a significant positive correlation between BMI and EFT (<i>r</i> = 0.379, <i>p</i> < 0.001) and a significant negative correlation between CVI and EFT (<i>r</i> = -0.412, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>The CVI value was significantly lower and the EFT value was significantly higher in patients with hypertension compared to non-hypertensive patients. There was a significant positive correlation between EFT and BMI and a significant negative correlation between EFT and CVI.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138458040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving cardiac function of angiotensin receptor/neprilysin inhibitor in patients with acute myocardial infarction: a systematic review and meta-analysis. 血管紧张素受体/奈普利素抑制剂改善急性心肌梗死患者心功能:系统回顾和荟萃分析。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-11-17 DOI: 10.5830/CVJA-2023-028
Qiuli Niu, Changyuan Wang, Xiurong Xing

Aim: As the impact of angiotensin receptor/neprilysin inhibitor (ARNI) on cardiac function in acute myocardial infarction (AMI) patients is unclear in clinical therapy, we conducted this research to investigate the actual effects of improving cardiac function with ARNI in AMI patients.

Methods: Publications were checked up to June 2022. Standardised mean differences (SMD) and 95% confidence intervals (CI) were utilised for assessing the size of the effect of continuous variables. To assess the magnitude of the effect of dichotomous variables, a relative risk (RR) with 95% CI was used.

Results: ARNI could improve left ventricular ejection fraction (SMD = 0.40; 95% CI: 0.23 - 0.58), while lowering left ventricular end-diastolic volume (SMD = -0.43, 95% CI: -0.78 to -0.08), left ventricular end-systolic volume (SMD = -0.39, 95% CI: -0.66 to -0.11) and left ventricular enddiastolic diameter (SMD = -0.49; 95% CI: -0.65 to -0.33). Besides, it could decrease the rates of major adverse cardiac events (RR = 0.55; 95% CI: 0.43 - 0.69) and heart failure (RR = 0.42; 95% CI: 0.31 - 0.58).

Conclusion: ARNI could greatly improve cardiac function in AMI patients.

目的:由于血管紧张素受体/奈普利素抑制剂(ARNI)在临床治疗中对急性心肌梗死(AMI)患者心功能的影响尚不明确,我们开展本研究,探讨ARNI对AMI患者心功能改善的实际效果。方法:查阅截至2022年6月的出版物。使用标准化平均差异(SMD)和95%置信区间(CI)来评估连续变量影响的大小。为了评估二分类变量的影响程度,使用95% CI的相对危险度(RR)。结果:ARNI可改善左室射血分数(SMD = 0.40;95% CI: 0.23 ~ 0.58),同时降低左室舒张末期容积(SMD = -0.43, 95% CI: -0.78 ~ -0.08)、左室收缩末期容积(SMD = -0.39, 95% CI: -0.66 ~ -0.11)和左室舒张末期直径(SMD = -0.49;95% CI: -0.65 ~ -0.33)。此外,它可以降低主要心脏不良事件的发生率(RR = 0.55;95% CI: 0.43 - 0.69)和心力衰竭(RR = 0.42;95% ci: 0.31 - 0.58)。结论:ARNI能明显改善AMI患者心功能。
{"title":"Improving cardiac function of angiotensin receptor/neprilysin inhibitor in patients with acute myocardial infarction: a systematic review and meta-analysis.","authors":"Qiuli Niu, Changyuan Wang, Xiurong Xing","doi":"10.5830/CVJA-2023-028","DOIUrl":"https://doi.org/10.5830/CVJA-2023-028","url":null,"abstract":"<p><strong>Aim: </strong>As the impact of angiotensin receptor/neprilysin inhibitor (ARNI) on cardiac function in acute myocardial infarction (AMI) patients is unclear in clinical therapy, we conducted this research to investigate the actual effects of improving cardiac function with ARNI in AMI patients.</p><p><strong>Methods: </strong>Publications were checked up to June 2022. Standardised mean differences (SMD) and 95% confidence intervals (CI) were utilised for assessing the size of the effect of continuous variables. To assess the magnitude of the effect of dichotomous variables, a relative risk (RR) with 95% CI was used.</p><p><strong>Results: </strong>ARNI could improve left ventricular ejection fraction (SMD = 0.40; 95% CI: 0.23 - 0.58), while lowering left ventricular end-diastolic volume (SMD = -0.43, 95% CI: -0.78 to -0.08), left ventricular end-systolic volume (SMD = -0.39, 95% CI: -0.66 to -0.11) and left ventricular enddiastolic diameter (SMD = -0.49; 95% CI: -0.65 to -0.33). Besides, it could decrease the rates of major adverse cardiac events (RR = 0.55; 95% CI: 0.43 - 0.69) and heart failure (RR = 0.42; 95% CI: 0.31 - 0.58).</p><p><strong>Conclusion: </strong>ARNI could greatly improve cardiac function in AMI patients.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138458037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular Journal of Africa
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1